Phase 2 combination clinical trial of ABI-H0731
Phase of Trial: Phase II
Latest Information Update: 12 Apr 2018
At a glance
- Drugs ABI-H0731 (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 12 Apr 2018 According to an Assembly Biosciences media release, The company anticipates results from these studies during the first half of 2019.
- 10 Apr 2018 New trial record
- 05 Apr 2018 According to an Assembly Biosciences media release, this trial is expected to begin in mid-2018 and potentially have initial data in the second half of 2018.